Page last updated: 2024-08-22

camptothecin and Pneumonia

camptothecin has been researched along with Pneumonia in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (30.77)29.6817
2010's3 (23.08)24.3611
2020's6 (46.15)2.80

Authors

AuthorsStudies
Acharyya, S; Bazhenova, L; Cheng, Y; Felip, E; Goto, Y; Jänne, PA; Li, BT; Mazières, J; Nagasaka, M; Nakagawa, K; Pacheco, JM; Paz-Ares, L; Pérol, M; Planchard, D; Saltos, AN; Saxena, K; Shahidi, J; Shiga, R; Smit, EF; Udagawa, H; Vitazka, P1
Bako, E; Cathcart, J; Chiu, JWY; Chung, CF; Chung, WP; Cortés, J; Curigliano, G; Hamilton, E; Hegg, R; Huang, CS; Hurvitz, SA; Im, SA; Iwata, H; Kim, JH; Kim, MH; Kim, SB; Lee, C; Liu, Y; Park, YH; Pedrini, JL; Petry, V; Tseng, LM; Verma, S; Xu, B1
Andre, F; Bartholmai, BJ; Conte, P; Kato, T; Lancaster, LH; Li, BT; Naidoo, J; Nicholson, AG; Nishino, M; Powell, CA; Schumacher-Wulf, E; Shitara, K; Swain, SM; Tsurutani, J1
Abuhelwa, Z; Alloghbi, A; Alqahtani, A; Nagasaka, M1
Camidge, DR; Chang, DY; Iwata, H; Macpherson, E; Modi, S; Powell, CA; Qin, A; Shire, N; Siena, S; Singh, J; Smit, EF; Taitt, C; Takahashi, S1
Camidge, DR; Danysh, HE; Hackshaw, MD; Iwata, H; Ladner, A; Powell, CA; Ritchey, ME; Singh, J; Taitt, C1
Allendorf, DJ; Bordoni, RE; Dixon, PM; Grant, SC; Jerome, ML; Miley, DK; Reddy, VB; Robert, F; Saleh, MN; Singh, KP1
Casey, DA; Chou, AJ; Merchant, MS; Merola, PR; Meyers, PA; Price, AP; Wexler, LH1
Fukuda, H; Fukuoka, M; Kawahara, M; Kudoh, S; Nakagawa, K; Negoro, S; Saijo, N; Sawa, T; Semba, H; Takeda, K; Tanaka, M1
Gemma, A; Kakihata, K; Kon, A; Nagashima, M; Suzuki, T; Yoshii, N1
Ikehara, M; Noda, K; Nomura, I; Oshita, F; Tanaka, G; Yamada, K1
Ajani, JA; Cox, JD; Komaki, R; Liao, Z; Liu, H; Swisher, S; Tucker, SL; Vaporciyan, AA; Wang, SL; Wei, X1
Büscher, C; Fähndrich, S; Fietkau, R; Klautke, G; Semrau, S; Virchow, C1

Reviews

3 review(s) available for camptothecin and Pneumonia

ArticleYear
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management.
    Cancer treatment reviews, 2022, Volume: 106

    Topics: Camptothecin; Humans; Immunoconjugates; Lung Diseases, Interstitial; Pneumonia; Trastuzumab

2022
Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review.
    Drugs, 2022, Volume: 82, Issue:9

    Topics: Adult; Camptothecin; Carcinoma, Non-Small-Cell Lung; Humans; Immunoconjugates; Lung Diseases, Interstitial; Lung Neoplasms; Pneumonia; Receptor, ErbB-2; Trastuzumab

2022
Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer.
    Breast cancer research and treatment, 2020, Volume: 183, Issue:1

    Topics: Ado-Trastuzumab Emtansine; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Disease Management; Drug Monitoring; Everolimus; Female; Humans; Immunoconjugates; Incidence; Lapatinib; Lung Diseases, Interstitial; Neoplasm Metastasis; Paclitaxel; Pneumonia; Receptor, ErbB-2; Trastuzumab

2020

Trials

7 trial(s) available for camptothecin and Pneumonia

ArticleYear
Trastuzumab Deruxtecan in
    The New England journal of medicine, 2022, 01-20, Volume: 386, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Camptothecin; Carcinoma, Non-Small-Cell Lung; Female; Follow-Up Studies; Humans; Immunoconjugates; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Pneumonia; Progression-Free Survival; Receptor, ErbB-2; Trastuzumab

2022
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
    The New England journal of medicine, 2022, 03-24, Volume: 386, Issue:12

    Topics: Ado-Trastuzumab Emtansine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Breast Neoplasms; Camptothecin; Female; Humans; Immunoconjugates; Kaplan-Meier Estimate; Lung Diseases, Interstitial; Middle Aged; Pneumonia; Progression-Free Survival; Receptor, ErbB-2; Trastuzumab

2022
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC).
    Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Biomarkers, Tumor; Brain Diseases, Metabolic; Camptothecin; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Endonucleases; Etoposide; Fatigue; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Mitosis; Multiple Organ Failure; Pneumonia; Treatment Outcome; Weight Loss

2015
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.
    Pediatric blood & cancer, 2009, Volume: 53, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Camptothecin; Child; Child, Preschool; Colitis; Dacarbazine; Diarrhea; Female; Humans; Irinotecan; Male; Neutropenia; Pneumonia; Recurrence; Remission Induction; Retrospective Studies; Sarcoma, Ewing; Temozolomide; Thrombocytopenia; Young Adult

2009
A phase II study of cisplatin and irinotecan as induction chemotherapy followed by concomitant thoracic radiotherapy with weekly low-dose irinotecan in unresectable, stage III, non-small cell lung cancer: JCOG 9706.
    Japanese journal of clinical oncology, 2011, Volume: 41, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Esophagitis; Female; Humans; Incidence; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonia; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Remission Induction; Severity of Illness Index

2011
Dose escalation study of paclitaxel in combination with fixed-dose irinotecan in patients with advanced non-small cell lung cancer (JCOG 9807).
    Oncology, 2004, Volume: 66, Issue:2

    Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Incidence; Irinotecan; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pneumonia; Treatment Outcome

2004
Simultaneous chemoradiotherapy with irinotecan and cisplatin in limited disease small cell lung cancer: a phase I study.
    Lung cancer (Amsterdam, Netherlands), 2006, Volume: 53, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Disease Progression; Dose Fractionation, Radiation; Esophagitis; Feasibility Studies; Female; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Pneumonia; Radiotherapy, Adjuvant; Remission Induction; Thrombocytopenia; Treatment Outcome

2006

Other Studies

3 other study(ies) available for camptothecin and Pneumonia

ArticleYear
Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies.
    ESMO open, 2022, Volume: 7, Issue:4

    Topics: Aged; Camptothecin; Humans; Immunoconjugates; Lung Diseases, Interstitial; Pneumonia; Retrospective Studies; Trastuzumab

2022
Clarification of clinical features of interstitial lung disease induced by irinotecan based on postmarketing surveillance data and spontaneous reports.
    Anti-cancer drugs, 2011, Volume: 22, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Drug Hypersensitivity; Female; Humans; Irinotecan; Lung Diseases, Interstitial; Male; Middle Aged; Neoplasms; Pneumonia; Product Surveillance, Postmarketing; Pulmonary Alveoli; Steroids; Tomography, X-Ray Computed

2011
Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
    International journal of radiation oncology, biology, physics, 2006, Mar-01, Volume: 64, Issue:3

    Topics: Analysis of Variance; Camptothecin; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Irinotecan; Length of Stay; Logistic Models; Lung; Male; Pneumonia; Postoperative Complications; Radiotherapy Dosage; Radiotherapy, Conformal; Respiratory Distress Syndrome; Retrospective Studies; Sex Factors; Statistics, Nonparametric

2006